[
  {
    "ts": null,
    "headline": "Health Care Drops on Reform Fears - Health Care Roundup",
    "summary": "Health-care companies fell sharply as traders rotated out of the sector in light of regulatory risks. The recent comprehensive budget bill that failed to pass Congress contained a rare and...",
    "url": "https://finnhub.io/api/news?id=c56c69d532475bbcea7a2f211ee9e44e3b38bb8c20cd08b74e91f97493fc102d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735577797,
      "headline": "Health Care Drops on Reform Fears - Health Care Roundup",
      "id": 132206162,
      "image": "",
      "related": "CI",
      "source": "Finnhub",
      "summary": "Health-care companies fell sharply as traders rotated out of the sector in light of regulatory risks. The recent comprehensive budget bill that failed to pass Congress contained a rare and...",
      "url": "https://finnhub.io/api/news?id=c56c69d532475bbcea7a2f211ee9e44e3b38bb8c20cd08b74e91f97493fc102d"
    }
  },
  {
    "ts": null,
    "headline": "Drug Middlemen Spared by Trump and Musk, for Now",
    "summary": "Tucked into the bipartisan budget deal that President-elect  Donald Trump’s  allies torpedoed earlier this month was a rare and significant attempt to reform the mechanics of America’s drug-pricing system.  Americans are broadly aware of how big pharma profits from high drug prices, but few understand the market distortions introduced by pharmacy benefit management (PBM) companies that negotiate prices on behalf of employers, insurers and government programs.",
    "url": "https://finnhub.io/api/news?id=f46b69a891dc4086d7e9df1c9af657770eebe7d7eae3125bd692a48e06dede5d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735554600,
      "headline": "Drug Middlemen Spared by Trump and Musk, for Now",
      "id": 132201376,
      "image": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
      "related": "CI",
      "source": "Yahoo",
      "summary": "Tucked into the bipartisan budget deal that President-elect  Donald Trump’s  allies torpedoed earlier this month was a rare and significant attempt to reform the mechanics of America’s drug-pricing system.  Americans are broadly aware of how big pharma profits from high drug prices, but few understand the market distortions introduced by pharmacy benefit management (PBM) companies that negotiate prices on behalf of employers, insurers and government programs.",
      "url": "https://finnhub.io/api/news?id=f46b69a891dc4086d7e9df1c9af657770eebe7d7eae3125bd692a48e06dede5d"
    }
  }
]